ClinicalTrials.gg
CompletedNCT04945486Updated Sep 15, 2023

The Effect of Peer-mentor Support for Older Vulnerable Patients With Ischemic Heart Disease

An interventional study of Peer-mentor intervention in Ischemic Heart Disease, sponsored by University College Copenhagen. Completed at 2 sites in Denmark. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2023-09-15.

Sponsored by University College Copenhagen · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
117
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 95 studies in Myocardial Ischemia with a site in Denmark — 20 open to participants now, 25 under way, 2 of them phase 3. Myocardial Ischemia · Denmark.

Enrollment
51st of 75
117 · median 300
Started
2021
with 6 others
No phase
48 of 95
10 open now
Registered
72nd of 95
by date

Among the 95 studies in Myocardial Ischemia with a site in Denmark, this one is the 51st largest by enrollment of the 75 interventional ones that give a count, is one of 7 that started in 2021, is one of 48 with no phase, and was the 72nd registered.

Myocardial Ischemia

1,123 studies on the registry are indexed under Myocardial Ischemia; 177 are open to participants now.

Browse Myocardial Ischemia studies →

Open to participants now

20 of the 95 studies in Myocardial Ischemia with a site in Denmark are open now. Recruiting first, the newest first:

15 more — sign in →

All 20 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 135 Myocardial Ischemia studies recruiting now, 92 (68%) set no upper age limit and 6 (4%) stop at 75 or younger; 14 take children under 18; 20 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 95 studies in Myocardial Ischemia with a site in Denmark, or all of them as a file.
02

Study summary

BACKGROUND: Advanced treatment regimens have reduced cardiovascular mortality resulting in an increasingly older Ischemic Heart Disease (IHD) population in need of cardiac rehabilitation (CR) , the majority (74%) is above 60 years. The positive effect of CR is well established; CR reduces cardiovascular mortality, lowers hospital admissions, and improves quality of life among patients with IHD. These positive effects of CR has also been established among older patients. The inherent problem lies in the low attendance rate, often below 50%. Several studies, including studies from Denmark, have shown that low participation in CR is most prevalent among older, vulnerable and female patients. The notion vulnerable covers patients with low socioeconomic position (SEP), patients with non-western background and patients living alone, as these groups have particularly low CR attendance. Effective interventions aiming at increasing CR attendance among these low attending groups are thus warranted and the current study will seek to address this.

AIM: To test the effect of a peer-mentor intervention among older vulnerable IHD patients.

DESIGN AND METHODS: The study is designed as a two arm RCT-study applying mixed methods.

Power calculations were based upon primary outcome 'Cardiac rehabilitation (CR) attendance'. Proportion attending CR in control group was set at 25% and intervention group at 50% based upon previous research. With a 5% significance level and 80% power. 110 patients were required (55 in each group) to have a 80% chance of detecting, as significant at the 5% level, an increase in the primary outcome measure from 25% in the control group to 50% in the experimental group.

Expected dropout was 6%. I.e., in total 117 patients are enrolled.

Patients (n=117) are recruited by a dedicated research nurse before discharge from the cardiology department at Nordsjællands Hospital and randomized (with 1:1 individual randomisation) to peer-mentor intervention or usual care. Data is collected through both qualitative and quantitative data (mixed methods). Data is collected at three timepoints, baseline, 12 weeks and 24 weeks. The patients (mentees) are matched with peer-mentors. Peer-mentoring (i.e. mentoring by a person with a similar life situation or health problem as one self) is a low-cost intervention that holds the potential to improve CR attendance and improve physical and psychological outcomes among older patients. Peer-mentors are role models who can guide and support patients overcoming barriers of CR attendance. Peer-mentoring is unexplored in a CR setting among older, female and vulnerable IHD patients; establishing the novelty of the current study.

03

Conditions studied

  • Ischemic Heart Disease

Browse trials for

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥65 years and diagnosed with IHD and referred to CR and female or low SEP or single living or non-western background

Exclusion criteria

Exclusion Criteria:

  • Patients unable to provide written consent
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
117 participants (actual)

Study arms

  • Experimental
    Peer-mentoring

    The patients (mentees) are matched with a peer-mentor i.e. a person with a similar life situation or health problem as one self

    Other: Peer-mentor intervention

  • No intervention
    Usual care

    Usual care provided by professional healthcare workers

Interventions

  • OtherPeer-mentor intervention

    Peer-mentor support for up to 6 months

06

What researchers measure

Primary outcomes

  1. Cardiac rehabilitation attendance

    Measured as 'self-reported CR attendance'

    Time frame: 24 weeks

Secondary outcomes

  1. Change in Health-related Quality of Life

    Measured using the 'HeartQoL' 'Health-related Quality of Life Questionnaire'. Min. score: 0, max score: 42. Higher scores indicating a better outcome.

    Time frame: Baseline to 24 weeks

  2. Change in Self-efficacy

    Measured using the questionnaire 'General self-efficacy scale'. Min score: 10, max score: 40. Higher scores indicating a better outcome

    Time frame: Baseline to 24 weeks

  3. Change in symptoms of anxiety and depression

    Measured using the questionnaire 'The hospital anxiety and depression scale' (HADS). Min. score: 0, max score 42. Lower scores indicating a better outcome

    Time frame: Baseline to 24 weeks

  4. Change in dietary quality

    Measured using the questionnaire 'Heartdiet'. Higher scores indicating a better outcome

    Time frame: Baseline to 24 weeks

  5. Change in physical activity

    Measured using the questionnaire 'Heartdiet'. Higher scores indicating a better outcome

    Time frame: Baseline to 24 weeks

  6. Qualitative content of disease trajectory

    Semi-structured qualitative interviews with patients (n=20-25)

    Time frame: Baseline to 24 weeks

07

Study locations

2 sites
  • Nordsjællands Hospital - Frederikssund
    Frederikssund, Denmark
  • Nordsjællands Hospital - Hillerød
    Hillerød, Denmark
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2021 to primary completion in Aug 2023, 24 months.

Of 155 non-industry interventional studies with no phase under Myocardial Ischemia, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 56. This study's 24 months is below that.

Counting every sponsor, half of 192 studies reached it within 34 months; a quarter within 15 and three quarters within 58.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 22, 2021
First posted
Jun 30, 2021
StartActual
Aug 2, 2021
Primary completionActual
Aug 25, 2023
CompletionActual
Aug 25, 2023
Last update
Sep 15, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 15, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04945486
Lead sponsor
University College Copenhagen
Collaborators
Nordsjællands Hospital
Responsible party
Maria Kjøller Pedersen (Associate Professor, University College Copenhagen) — Principal investigator
First posted
Jun 30, 2021
Start date
Aug 2, 2021
Primary completion
Aug 25, 2023
Completion
Aug 25, 2023
Last update
Sep 15, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion